MONOCLONAL ANTIBODIES AGAINST ANTITHROMBIN BETA COMPLEXED WITH HEPARIN
European Patent Office Patent
Stats

Importance

EP Family Size
|
Non-US Coverage
|
Abstract
This patent document relates to antibodies, antigen-binding antibody fragments (Fabs), and other protein scaffolds, directed against human antithrombin β complexed with heparin and/or heparin-like structure (ΑΤβΗ). These ΑΤβΗ binding proteins can block the anti-coagulant activity of ΑΤβ to induce coagulation. Therapeutic uses of these antibodies and binders are described herein as are methods of panning and screening specific antibodies.

First Claim
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations

Patent Owner(s)
Patent Owner | Address |
---|---|
BAYER HEALTHCARE LLC | USWHIPPANY NJ 0781-1544 |
International Classification(s)
Inventor(s)
Inventor Name | Address |
---|---|
DITTMER FRANK | VENNSTR 42 40627 DÜSSELDORF |
MURPHY JOHN E | CHIRON CORPORATION INTELLECTUAL PROPERTY - R440 P O BOX 8097 EMERYVILLE CA 94662-8097 |
GRITZAN UWE | SCHIRMERSTRASSE 20 50823 KÖLN 50823 |
HERMISTON TERRY | MILL VALLEY CA 94941 |
STRERATH MICHAEL | DÜESSELDORF |
JIN YE | 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CALIFORNIA 94043 94043 |
MYLES TIMOTHY | SUNNYVALE CA |
Cited Art Landscape
- No Cited Art to Display

Full Text

Legal Events

Matter Detail

Renewals Detail

Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:

Add to additional portfolios:

Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement

Recipient Email Address

Recipient Email Address

Comment
Recipient Email Address

Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.